| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/21/2004 | EP1169023B1 Process for the prepartation of SOLUBILIZING AIDS IN POWDER FORM FOR SOLID PHARMACEUTICAL PRESENTATION FORMS |
| 01/21/2004 | EP1150660B1 Pharmaceutical effervescent formulation containing metamizol |
| 01/21/2004 | EP1128826B1 Chromone enteric release formulation |
| 01/21/2004 | EP1077680B1 Method of fabricating a banded prolonged release active agent dosage form |
| 01/21/2004 | EP0944397B1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 01/21/2004 | EP0792164B1 Composition, device, and method for enhanced electrotransport agent delivery |
| 01/21/2004 | CN1469880A Pharmaceutical compositions |
| 01/21/2004 | CN1469877A Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| 01/21/2004 | CN1469868A Use of triazinetrione sulfones for combating coccidiosis |
| 01/21/2004 | CN1469753A Method of forming polypeptide particles |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/21/2004 | CN1469747A Use of triazinetrione sulfoxides for controlling coccidioses |
| 01/21/2004 | CN1469744A Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 01/21/2004 | CN1469738A Soft capsules comprising a starch mixture having reduced branching degree |
| 01/21/2004 | CN1469737A Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 01/21/2004 | CN1469736A Use of a porous carrier |
| 01/21/2004 | CN1469735A Liposomal formulation of mitoxantrone |
| 01/21/2004 | CN1469734A Pharmaceutical form of administration for peptides, method for its production and use |
| 01/21/2004 | CN1469733A Method for producing powdery formulations |
| 01/21/2004 | CN1469707A Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
| 01/21/2004 | CN1468867A Soluble high branched glucose polymer and its producing process |
| 01/21/2004 | CN1468632A Growth hormone for ovarian functional cell and is prepn |
| 01/21/2004 | CN1468606A Smoking-quiting gettama cigarette |
| 01/21/2004 | CN1468602A Application of naringin in preparing medicine for supporting treatment of SARS |
| 01/21/2004 | CN1468598A Slow-released indapamide capsule and its prepn process |
| 01/21/2004 | CN1468597A Continuous released medical composition |
| 01/21/2004 | CN1468596A Liposome producing process and apparatus |
| 01/21/2004 | CN1468595A Honeyed liver and kidney soft extract |
| 01/21/2004 | CN1135103C Controlled release drugs delivered through sublingual or buccal administration |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680341 Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor |
| 01/20/2004 | US6680337 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/20/2004 | US6680334 A new crystalline, pharmaceutically acceptable form of amlodipine free base; antiischemic agents; hypotensive agents; cardiotonic agents; storage stability; isolating amlodipine free base, crystallising using solvent(s) |
| 01/20/2004 | US6680320 Urokinase inhibitors |
| 01/20/2004 | US6680305 Physiologically acceptable aqueous solutions and methods for their use |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | US6680284 Method for producing powdery particle-reduced formulations with the aid of compressed gases |
| 01/20/2004 | US6680211 Fluorescent nanocrystal-embedded microspheres for fluorescence analysis |
| 01/20/2004 | US6680072 Producing small, rapidly disintegrating masked tablets; st. john's wort |
| 01/20/2004 | US6680071 Opioid agonist in a fast dispersing dosage form |
| 01/20/2004 | US6680070 High impact strength shape retentive material comprised of such as halogenated hydantoin and micronized polyolefin and/or polyfluorocarbon wax binder |
| 01/20/2004 | US6680069 Low-substituted hydroxypropyl cellulose and process for manufacturing the same |
| 01/20/2004 | US6680068 For therapy of tumors |
| 01/20/2004 | US6680067 Analgesic in admixture with injectable oil; nalbuphine free base or a pharmaceutically acceptable salt |
| 01/20/2004 | US6680046 Preventing catheter clogging using uniform, high impact strength particles |
| 01/20/2004 | US6679605 Crystalline polymeric compositions for ophthalmic devices |
| 01/20/2004 | US6679249 Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
| 01/20/2004 | US6678998 Floral packaging material having great masters prints thereon |
| 01/20/2004 | CA2379887C Stable tablets comprising simvastatin |
| 01/20/2004 | CA2241247C Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles |
| 01/20/2004 | CA2208322C Directly compressible high load acetaminophen formulations |
| 01/20/2004 | CA2157323C Gepirone dosage form |
| 01/20/2004 | CA2140254C Controlled release morphine preparation |
| 01/20/2004 | CA2131226C Veterinary tablet rather designed for cats |
| 01/20/2004 | CA2120751C Trimethoprim oral liquid |
| 01/20/2004 | CA2119057C An aqueous liposome system and a method for the preparation of such a liposome system |
| 01/20/2004 | CA2110041C Method of producing reproducible particles |
| 01/20/2004 | CA2101095C Enteric coated soft capsules and method of preparation thereof |
| 01/20/2004 | CA2083027C Formation of protein microparticles by antisolvent precipitation |
| 01/20/2004 | CA2075458C Melt crystallised xylitol |
| 01/15/2004 | WO2004006454A1 Filters for combined radiotelephone/gps terminals |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005430A1 Catalyst for conversion processes |
| 01/15/2004 | WO2004005429A1 Catalyst for conversion processes |
| 01/15/2004 | WO2004005306A2 Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object |
| 01/15/2004 | WO2004005227A1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 01/15/2004 | WO2004004798A2 Central airway administration for systemic delivery of therapeutics |
| 01/15/2004 | WO2004004786A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | WO2004004783A1 Liquid compositions for the oral administration of lorazepam |
| 01/15/2004 | WO2004004781A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 01/15/2004 | WO2004004780A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| 01/15/2004 | WO2004004779A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 01/15/2004 | WO2004004775A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 01/15/2004 | WO2004004768A1 Microparticle with cd28-specific monoclonal antibodies |
| 01/15/2004 | WO2004004758A1 Method to enhance an immune response of nucleic acid vaccination |
| 01/15/2004 | WO2004004757A1 Treatment for eye disorder |
| 01/15/2004 | WO2004004747A1 Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid |
| 01/15/2004 | WO2004004745A1 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 01/15/2004 | WO2004004744A1 Compositions of hyaluronic acid and methods of use |
| 01/15/2004 | WO2004004739A1 Ciclesonide-containing sterile aqueous suspension |
| 01/15/2004 | WO2004004738A1 Remedy or preventive for keratoconjunctival epithelial cell injury |
| 01/15/2004 | WO2004004737A1 Cephalosporin preparation for oral use |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004724A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | WO2004004719A1 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/15/2004 | WO2004004718A1 Liquid dosage forms of acid labile drugs |
| 01/15/2004 | WO2004004717A1 Pharmaceutical composition comprising (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
| 01/15/2004 | WO2004004716A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | WO2004004709A1 Gel injection treatment of body parts |
| 01/15/2004 | WO2004004705A2 Pharmaceutical formulations for preparing drink products |
| 01/15/2004 | WO2004004704A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 01/15/2004 | WO2004004696A1 Controlled release composition |
| 01/15/2004 | WO2004004695A1 Extended-release tablets comprising divalproex sodium |
| 01/15/2004 | WO2004004694A1 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 01/15/2004 | WO2004004693A1 Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| 01/15/2004 | WO2004004692A1 Processes for the preparation of oral dosage formulations of modafinil |
| 01/15/2004 | WO2004004691A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| 01/15/2004 | WO2004004690A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | WO2004004689A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/15/2004 | WO2004004688A1 Injectable system for controlled drug delivery |